A detailed history of Summit Global Investments transactions in Vericel Corp stock. As of the latest transaction made, Summit Global Investments holds 20,831 shares of VCEL stock, worth $1.19 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
20,831
Previous 10,140 105.43%
Holding current value
$1.19 Million
Previous $465,000 89.25%
% of portfolio
0.06%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$42.25 - $53.56 $451,694 - $572,609
10,691 Added 105.43%
20,831 $880,000
Q2 2024

Jul 22, 2024

BUY
$41.71 - $52.9 $422,939 - $536,406
10,140 New
10,140 $465,000
Q1 2022

Apr 29, 2022

SELL
$31.69 - $43.29 $567,251 - $774,891
-17,900 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$35.2 - $52.6 $246,400 - $368,200
7,000 Added 64.22%
17,900 $703,000
Q3 2021

Nov 08, 2021

BUY
$46.35 - $59.75 $505,215 - $651,275
10,900 New
10,900 $532,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.